Aged Versus Fresh White Tea: Decade of Storage Reshapes Anti-Obesity Effects in Mice

A cup of white tea may deliver very different metabolic benefits depending on how long the leaves have sat in storage, according to a new mouse study that put a ten-year-aged white tea head-to-head with a freshly produced counterpart. The research, published in Current Research in Food Science, found that while both infusions improved glucose and lipid metabolism in obese mice fed a high-fat diet, the aged tea excelled at protecting the liver and lowering cholesterol-linked blood lipids, whereas the new tea proved more effective at trimming body weight. Behind that divergence lies a striking chemical story: over a decade of storage, the tea’s phytochemical profile transforms so thoroughly that the two infusions act on the body through partly distinct molecular and microbial pathways.

The study, led by Linmei Liu, Hongzhe Zeng, and colleagues at Hunan Agricultural University in China, compared Shoumei white teas sourced from Zhenghe County in Fujian province. Chemical profiling revealed substantial storage-associated differences. The aged white tea contained significantly higher concentrations of gallic acid, caffeine, thearubigins, and theabrownin, reflecting the slow oxidative polymerization of catechins into larger pigmented molecules over time. The newly produced tea, by contrast, was richer in total tea polyphenols, free amino acids, theobromine, and intact monomeric catechins, including roughly double the epigallocatechin gallate (EGCG) found in the aged sample. Untargeted metabolomics using ultra-performance liquid chromatography coupled to mass spectrometry identified 112 compounds across the two infusions, with six showing statistically significant accumulation differences. Two galloylated glucose derivatives and L-glutamine were enriched in the new tea, while guanine, cytosine, and nicotinic acid were more abundant in the aged tea.

To test the biological consequences of these compositional shifts, the researchers fed six-week-old male C57BL/6J mice a diet in which sixty percent of calories came from fat, a standard model for inducing obesity and metabolic syndrome. The animals were divided into four groups of eight: one received standard chow with plain water, one received the high-fat diet with plain water, and the remaining two received the high-fat diet with unlimited access to either the aged or the new white tea infusion as their drinking water. Notably, the team chose ad libitum access to tea infusions rather than the intragastric gavage used in many previous studies, because forced administration can damage the bioactivity of plant compounds and provoke stress responses in animals that disturb glucose-lipid homeostasis and confound the results. The free-access approach also more closely mirrors how people actually drink tea.

Over the four-week intervention, both teas significantly counteracted the high-fat diet’s effects. Obese model mice displayed elevated final body weight, a higher Lee’s index of adiposity, enlarged subcutaneous and epididymal fat depots, increased food and energy intake, and greater energy efficiency. Both tea treatments lowered body weight, reduced adipose tissue masses, and restored a more compact body conformation, with visibly reduced abdominal fat deposition. The newly produced tea, however, achieved a significantly greater reduction in final body weight than the aged tea and showed a stronger capacity to lower energy efficiency, the fraction of consumed energy retained by the animal. Fluid intake was lower in the tea groups, likely reflecting transient behavioral accommodation to the sensory properties of the infusions, but the researchers confirmed that comparable consumption between the two tea groups validated the dose equivalence of the comparison.

Glucose homeostasis improved under both interventions. The high-fat diet produced hyperglycemia, hyperinsulinemia, and insulin resistance, as shown by elevated fasting blood glucose, elevated fasting serum insulin, and a higher homeostatic model assessment of insulin resistance index. Both teas significantly blunted these increases, indicating improved insulin sensitivity. The lipid picture was more revealing of the teas’ differences. Both lowered serum total cholesterol and LDL-cholesterol, but the aged tea achieved a significantly greater LDL reduction than the new tea. In the liver, the aged tea also significantly reduced hepatic cholesterol and serum aspartate aminotransferase, a marker of liver cell injury, whereas the new tea did not significantly alter these parameters relative to the untreated obese group. Histological examination of liver sections showed severe macrovesicular steatosis in untreated obese mice, with extensive fat droplets crowding the tissue, while both teas markedly reduced the number and size of lipid droplets.

Serum metabolomics helped explain what was happening systemically. The high-fat diet dramatically remodeled the serum metabolome, with 115 metabolites differing between lean and obese controls. Both teas partially normalized this disturbance, with glycerophospholipid metabolism emerging as a prominently affected pathway in multiple comparisons. Three metabolites in that pathway—1-hexadecyl-sn-glycero-3-phosphocholine, glycerophosphocholine, and choline—rose on the high-fat diet and fell in response to both teas. But each tea also carried a distinct metabolic signature: the aged tea significantly increased serum azelaic acid, a metabolite linked in prior research to lipolysis, lipid peroxidation, and inflammatory regulation, while the new tea significantly raised betaine, a compound previously shown in experimental studies to limit high-fat-diet-induced weight gain and adipose accumulation.

The gut microbiota emerged as a central player. Sixteen-ribosomal-RNA-gene sequencing of cecal contents showed that the high-fat diet significantly restructured microbial communities, reducing alpha-diversity, shifting community composition in principal coordinate analysis, and raising the abundance of Firmicutes. Both teas tended to restore diversity indices and lowered serum lipopolysaccharide, a marker of metabolic endotoxemia arising from compromised intestinal barrier function, with the aged tea producing the larger decrease in circulating LPS and a more consistent improvement across the richness and diversity measures. At the genus level, both teas reduced four candidate taxa—Solibacillus, Candidatus Saccharimonas, Adlercreutzia, and Faecalibaculum—that correlated positively with fat mass, fasting insulin, and cholesterol in the obese mice. The decisive divergence came from two other genera: the aged tea selectively increased Lachnospiraceae_NK4A136_group, a taxon associated with short-chain fatty acid production, while the new tea selectively enriched Akkermansia, a genus famous in microbiome research for its inverse associations with obesity.

Correlation analysis wove these threads together. The aged tea’s enriched constituents—gallic acid, theaflavins, guanine, thearubigins, nicotinic acid, caffeine, theabrownin, and cytosine—correlated positively with Lachnospiraceae_NK4A136_group and with azelaic acid, while the genus itself correlated negatively with LDL-cholesterol, serum LPS, and the liver injury marker AST. This suggests the aged tea’s hepatoprotective profile may operate through a gallic-acid-driven axis that restores Lachnospiraceae_NK4A136_group and boosts azelaic acid, though the short-chain fatty acid mechanism remains hypothetical because those metabolites were not directly quantified. The new tea’s abundant catechins, polyphenols, free amino acids, and theobromine instead correlated positively with betaine, which itself inversely tracked fasting blood glucose, body weight, fat pad masses, insulin resistance, and LDL-cholesterol—identifying betaine as a plausible intermediary for the new tea’s superior weight-lowering effect. Curiously, Akkermansia enrichment did not correlate with most metabolic endpoints in this study, leaving its role in the new tea’s phenotype an open question.

The findings carry an intriguing implication for consumers and researchers alike: the value of aged tea is not simply a faded version of fresh tea but a chemically transformed product with its own biological identity. Oxidative polymerization of catechins into theaflavins, thearubigins, and theabrownins over ten years of storage appears to shift the tea’s activity from body-weight regulation toward hepatic lipid homeostasis and endotoxin control. The authors caution, however, that their conclusions rest mainly on multi-omics correlation analysis and prior work from their group, so causality between the compound-microbe-metabolite relationships and the observed phenotypes is not yet established. They call for follow-up studies using fecal microbiota transplantation, targeted metabolite interventions, and germ-free animal models to confirm the proposed pathways.

For now, the study stands as one of the most comprehensive direct comparisons of aged versus newly produced white tea, combining phytochemical characterization, physiology, histopathology, serum metabolomics, and microbiome sequencing in a single experimental framework. It suggests that in the future, the choice between a young, catechin-rich white tea and a decade-aged, theabrownin-rich one might be tailored to a person’s specific metabolic priorities—weight management on one side, liver and lipid protection on the other. That nuance, emerging from an ordinary cup of tea steeped for five minutes in boiling water, underscores how profoundly storage chemistry and the gut microbiome shape the health effects of what we drink.

Subject of Research: Comparative effects of aged and newly produced white tea on glucose and lipid metabolism and the gut microbiota in obese mice

Article Title: Comparative Effects of Aged and Newly Produced White Tea on Glucose and Lipid Metabolism and the Gut Microbiota in Mice with High-Fat Diet-Induced Obesity

Article References: Liu, L., Zeng, H., Wan, L., Peng, L., Bai, Q., Yang, X., Li, H., Rao, H., Li, L., Xiong, X., Yu, H., Zheng, X., Huang, J., & Liu, Z. (2026). Comparative Effects of Aged and Newly Produced White Tea on Glucose and Lipid Metabolism and the Gut Microbiota in Mice with High-Fat Diet-Induced Obesity. Current Research in Food Science, Article 101597. https://doi.org/10.1016/j.crfs.2026.101597

Image Credits: AI Generated

DOI: Not provided

Keywords: white tea, obesity, gut microbiota, metabolomics, high-fat diet, insulin resistance, theabrownin, EGCG, betaine, azelaic acid, liver steatosis, glucose metabolism